# FDA Inspection 1291276 - Sichuan Xieli Pharmaceutical Co. Ltd. - September 26, 2025

Source: https://www.keypedia.com/records/fda_inspections/sichuan-xieli-pharmaceutical-co-ltd/a521d201-1a17-4a3e-a42e-f6886c959a5d
Source feed: FDA_Inspections

> FDA Inspection 1291276 for Sichuan Xieli Pharmaceutical Co. Ltd. on September 26, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1291276
- Company Name: Sichuan Xieli Pharmaceutical Co. Ltd.
- Inspection Date: 2025-09-26
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1291276 - 2025-09-26](https://www.keypedia.com/records/fda_inspections/sichuan-xieli-pharmaceutical-co-ltd/ab58798f-8322-49f6-b487-02501b7fa138)
- [FDA Inspection 1070481 - 2018-09-27](https://www.keypedia.com/records/fda_inspections/sichuan-xieli-pharmaceutical-co-ltd/55766941-67ba-4762-bf48-e815f8d28836)
- [FDA Inspection 980870 - 2016-07-01](https://www.keypedia.com/records/fda_inspections/sichuan-xieli-pharmaceutical-co-ltd/0ff223e9-e94a-4ca0-b36f-7e6d30c4d6ac)

Company: https://www.keypedia.com/companies/sichuan-xieli-pharmaceutical-co-ltd/d11d003a-5f7d-4752-85d9-2679deca0b24

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c